ITSA wins advertising and strategic communication mandate for HCL-Avitas

By afaqs! news bureau , afaqs!, New Delhi | In Advertising | July 01, 2015
The mandate was awarded at the end of a competitive pitch process which saw participation from agencies including the incumbent FCB Ulka, JWT and Equus.

ITSA has been awarded the advertising and strategic communication mandate for HCL-Avitas, the healthcare subsidiary of HCL group, pegged to be worth $6.5 billion. HCL-Avitas, in affiliation with Johns Hopkins Medicine International, is the healthcare delivery arm of HCL Healthcare. ITSA is now the full-service creative agency on record (AOR) for HCL-Avitas and its aim will be to create awareness using any media that can help build the brand in patient care.

Emmanuel Upputuru

Harish Natarajan

Starting with the country's first nationwide networked multispecialty clinics, HCL Avitas aims to provide the whole continuum of care for chronic and acute diseases. Currently operational in Delhi-NCR, it is set to witness an expansion across India in the near future. ITSA was awarded the mandate at the end of a competitive pitch process where the HCL-Avitas team evaluated presentations from different agencies including the incumbent FCB Ulka, JWT and Equus.

Commenting on the win, Emmanuel Upputuru, founder and creative chairman, ITSA, says, "ITSA is attracting clients that have new age offerings. HCL-Avitas is a bold idea in the highly sensitive and complicated healthcare sector. What I like is the intersection of technology and health to provide care."

Harish Natarajan, CEO, HCL-Avitas, shares, "Building a brand in advertising is about touching lives and making a difference to thousands of patients who experience the brand. Our patient-centric approach needed a creative partner that would understand, absorb and share the vision of the brand, and help create a deeper connect with our existing and potential patients. We believe that the passion, creativity and innovation that the ITSA team brings will help propel the brand in this early stage of its evolution. We look forward to a rewarding association and working towards making HCL-Avitas a household name in patient care."

Search Tags